LncRNA SNHG6 Upregulates KPNA5 to Overcome Gemcitabine Resistance in Pancreatic Cancer via Sponging miR-944

LncRNA SNHG6 Upregulates KPNA5 to Overcome Gemcitabine Resistance in Pancreatic Cancer via Sponging miR-944

Gemcitabine (GEM) is the gold-standard therapeutic regimen for patients with pancreatic cancer (PC); however, patients may receive limited benefits due to the drug resistance of GEM. LncRNA SNHG6 is reported to play key roles in drug resistance, but its role and molecular mechanism in PC remain inco...

Full description

Bibliographic Details
Main Authors: Ge Gao, Xin Li, Hui Wu, Ling-li Huang, Yu-xin Lin, Zhi Huo, Zhong-yuan Xiang, Xiao Zhou
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Pharmaceuticals
Subjects:
LncRNA SNHG6
Gemcitabine resistance
KPNA5
miR-944
pancreatic cancer
Online Access:https://www.mdpi.com/1424-8247/16/2/184

Similar Items

Similar Items